Company Malin Corporation plc

MLC

IE00BVGC3741

Pharmaceuticals

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Real-time Irish S.E. Other stock markets 11:55:00 2024-04-24 am EDT			5-day change	1st Jan Change
5.6 ^EUR	0.00%		0.00%	+24.44%

Mar. 28	Transcript : Malin Corporation plc - Shareholder/Analyst Call
Feb. 28	Tranche Update on Malin Corporation plc's Equity Buyback Plan announced on November 15, 2023.	CI

Malin Corporation Plc is a company investing in and supporting highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Its purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential.

Number of employees: 3

Managers	Title	Age	Since
Andrea Stafford DFI	Director of Finance/CFO	54	22-04-30
Ita Finegan ADM	Chief Administrative Officer	-	-
Fiona Dunlevy BRD	Director/Board Member	41	14-12-31

Members of the board	Title	Age	Since
William Daniel CHM	Chairman	72	15-02-28
Kirsten Drejer BRD	Director/Board Member	68	20-03-23
Jean-Michel Cossery BRD	Director/Board Member	65	18-07-15
Chris Pedrick BRD	Director/Board Member	-	22-04-25
Rudy Mareel BRD	Director/Board Member	61	18-07-15
Fiona Dunlevy BRD	Director/Board Member	41	14-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	81,982	0	0	72.49 %
Stock B	1	18,889,274	13,751,791 ( 72.80 %)	0

Name	Equities	%	Valuation
Woodford Investment Management Ltd. 50.39 %	9,476,842	50.39 %	59 M €
Sean Odriscoll 10.24 %	1,925,500	10.24 %	12 M €

Name	Equities	%	Valuation
POSEIDA THERAPEUTICS, INC. 12.27%	11,835,673	12.27%	37,755,797 $

Malin Corp. Plc

2 Harbour Square Crofton Road

2, Dublin

+353 1 901 5700

http://www.malinplc.com

Name	Category and Sector
Malin Life Sciences Holdings Ltd. Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin.	Financial Conglomerates

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.6 EUR

Average target price

11.7 EUR

Spread / Average Target

+109.02%

Consensus

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
MALIN CORPORATION PLC	+24.44%	113M
ELI LILLY AND COMPANY	+25.61%	660B
NOVO NORDISK A/S	+24.29%	562B
JOHNSON & JOHNSON	-5.24%	358B
MERCK & CO., INC.	+16.49%	322B
ABBVIE INC.	+8.28%	297B
ASTRAZENECA PLC	+12.57%	219B
ROCHE HOLDING AG	-9.61%	196B
NOVARTIS AG	+6.52%	199B
PFIZER, INC.	-8.75%	149B

Other Pharmaceuticals